Veritable, L.P. Novo Nordisk A S Transaction History

Veritable, L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $93,899 - $103,935	602 Added 7.35%	8,797 $1.42 Million
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $110,636 - $133,041	836 Added 11.36%	8,195 $1.3 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $105,934 - $139,795	1,033 Added 16.33%	7,359 $995,000
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $22,009 - $27,010	-231 Reduced 3.52%	6,326 $630,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $63,492 - $74,913	615 Added 10.35%	6,557 $731,000
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $120,936 - $146,189	1,299 Added 27.98%	5,942 $660,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $958 - $1,170	-10 Reduced 0.21%	4,643 $520,000
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $4,136 - $5,224	-49 Reduced 1.04%	4,653 $447,000
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $13,802 - $17,291	204 Added 4.54%	4,702 $394,000
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $59,079 - $66,797	881 Added 24.36%	4,498 $303,000
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $6,516 - $7,527	-102 Reduced 2.74%	3,617 $253,000
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $14,967 - $16,501	-235 Reduced 5.94%	3,719 $258,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $231,467 - $268,634	3,954 New	3,954 $259,000
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $289,630 - $347,270	-5,973 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $283,896 - $320,929	5,973	5,973 $322,000

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.